期刊文献+

某院生殖中心门诊超说明书用药调查分析 被引量:7

Investigution and Analysis of Off-label Drug Use in Fertility Clinic of One Hospital
下载PDF
导出
摘要 目的:分析某院生殖中心门诊超说明书用药情况,为临床合理用药提供科学依据,并进一步规范医师的超说明书用药行为。方法:抽取某院2016年1~12月生殖中心的门诊处方,根据药品说明书内容,对超说明书用药处方进行统计分析,并查询相关文献对超说明书药品进行合理性评价。结果:共收集到超说明书用药处方4 176张,超说明书用药类型包括超适应证用药、超剂量用药和超给药途径用药。超说明书用药比例排名前3位的药品是阿司匹林肠溶片(42.05%)、地屈孕酮片(27.37%)、左卡尼汀口服溶液(16.02%)。超说明书用药中多数有循证医学证据支持,但也存在不合理用药现象。结论:该院生殖中心超说明书用药现象普遍存在,医院应重视超说明书用药情况,并建立相关管理制度予以规范,从而降低超说明书用药的法律风险,促进医院合理用药水平。 Objective:To analyze the situation of off-label drug use in fertility clinic of one hospital to provide scientific evidence for clinical rational drug use and further standardize the behavior of off-label drug use in clinical physicians. Methods:The outpatient prescriptions in the reproductive center of the hospital during January and December in 2016 were randomly selected, the off-label drug use prescriptions were statistically analyzed according to the drug package inserts, and the rationality of the off-label drug use were e-valuated by searching the related literatures. Results:A total of 4176 off-label drug use prescriptions were collected, the primary types of off-label drug use were off-label indication, off-label dose and off-label administration. The top 3 drugs with off-label use were aspi-rin enteric-coated tablets (42. 05%), dydrogesterone tablets (27. 37%) and levocarnitine oral solution (16. 02%). The most of off-label use was supported by evidence-based medicines, while unreasonable use still existed. Conclusion: Off-label drug use is very common in the reproductive center of the hospital. The hospital should pay more attention to the phenomenon and establish relevant management system to standardize the behavior of off-label drug use in order to reduce the legal risk and promote clinical rational drug use.
出处 《中国药师》 CAS 2017年第10期1805-1808,共4页 China Pharmacist
关键词 生殖中心 超说明书用药 规范化管理 合理用药 Reproductive center Off-label drug use Standardized management Rational drug use
  • 相关文献

参考文献8

二级参考文献125

  • 1广东省药学会.药品未注册用法专家共识.2010年3月18日.
  • 2American Society of Hospital Pharmacists. ASHP statement on the use of medications for unlabeled uses. Am Hospital Pharm, 1992, 49(8): 2006-2008.
  • 3Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liver- pool Women's Hospital. The International ournal Of Pharmacy Practice, 2010, 18(4): 226-229.
  • 4Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BM, 2000, 320(7227): 79-82.
  • 5Hames A. Unlicensed and off-label drug use in elderly people. Age And Ageing, 2001, 30(6): 530-531.
  • 6Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypi- cal antipsychotic drugs in patients with Alzheimer's Disease. N Engl Med, 2006, 355(15): 1525-1538.
  • 7Huntzinger A. FDA warns against off-label use of antipsychotic drugs. Am Faro Physician, 2005, 71(61): 2205.
  • 8Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med, 2006, 166(9): 1021-1026.
  • 9Miller L. Rules set for dissemination of off-label-use information. Am Health-Syst Pharm, 1999, 56(3): 204-206.
  • 10Verordnungsfihigkeit von zugelassenen Arzneimitteln in nicht zugelassenen Anwendungsgebieten. Richtlinie des Gemeinsamen Bundesausschusses, 2009. Available at: URL: http://www.g-ba.de/ downloads/62 -492-470/AM-RL-2010-09-16_4.pdf.

共引文献334

同被引文献62

引证文献7

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部